Dynamic Technology Lab’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Dynamic Technology Lab’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,657	Closed	-$48K	–	1636
2021 Q4	$48K	Buy	+10,657	New	+$50.6K	0.01%	1061
2021 Q3	–	Sell	-19,556	Closed	-$133K	–	1568
2021 Q2	$133K	Buy	+19,556	New	+$158K	0.01%	977
2018 Q2	–	Sell	-12,422	Closed	-$162K	–	1402
2018 Q1	$162K	Buy	+12,422	New	+$185K	0.02%	924
2017 Q1	–	Sell	-10,279	Closed	-$158K	–	1337
2016 Q4	$158K	Buy	+10,279	New	+$133K	0.04%	766

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Dynamic Technology Lab's PRTK Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2022, closing a stake of 10,657 shares — an estimated $48K sold.

Dynamic Technology Lab first reported a position in PRTK in Q4 2016 and held it in 4 quarters. The position peaked at $162K in Q1 2018. 100 funds tracked by Wall St. Rank hold PRTK as of Q1 2022.

Dynamic Technology Lab reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Dynamic Technology Lab sold 10,657 Paratek Pharmaceuticals, Inc. shares in Q1 2022, an estimated $48K.
Dynamic Technology Lab first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
Dynamic Technology Lab's Paratek Pharmaceuticals, Inc. position peaked at $162K in Q1 2018.
100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.